Navigation Links
Circadian Receives FDA IND Approval to Begin Clinical Trials With VGX-100 for the Treatment of Cancer Patients With Solid Tumors
Date:10/31/2011

gned to assess the safety and efficacy of a drug prior to commercialisation and a significant proportion of drugs fail one or both of these criteria. Other risks include uncertainty of patent protection and proprietary rights, whether patent applications and issued patents will offer adequate protection to enable product development, the obtaining of necessary drug regulatory authority approvals and difficulties caused by the rapid advancements in technology. Companies such as Circadian are dependent on the success of their research and development projects and on the ability to attract funding to support these activities. Investment in research and development projects cannot be assessed on the same fundamentals as trading and manufacturing enterprises. Thus investment in companies specialising in drug development must be regarded as highly speculative. Circadian strongly recommends that professional investment advice be sought prior to such investments.

Forward-looking statements Certain statements in this ASX announcement may contain forward-looking statements regarding Company business and the therapeutic and commercial potential of its technologies and products in development. Any statement describing Company goals, expectations, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those risks or uncertainties inherent in the process of developing technology and in the process of discovering, developing and commercialising drugs that can be proven to be safe and effective for use as human therapeutics, and in the endeavor of building a business around such products and services. Circadian undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Actual results could differ materially from those discussed in this ASX announcement.


'/>"/>

SOURCE Circadian Technologies Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Circadian Files IND With FDA for VGX-100 for the Treatment of Cancer Patients With Solid Tumors
2. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
3. Cyberonics Receives FDA Approval for Expansion of MRI Use With VNS Therapy® Systems
4. Mylan Receives Approval for Generic Version of MS Contin® Tablets
5. SAFC Verona HPAPI Manufacturing Facility Receives SafeBridge Certification
6. INNOPHARMA Receives FDA Approval of Generic Olanzapine Injection
7. Accuray Receives 510(k) Clearance for a Rotational Dose Control for the TomoTherapy System
8. Neuralstem Receives FDA Approval to Dose Patients in Cervical Region in Ongoing ALS Trial
9. Covance Receives Good Laboratory Practice Certification for Its Early Development Facility in Shanghai, China
10. Boca Pharmacal Receives FDA Approval on Glycopyrrolate Tablets
11. Institute of Health Sciences Receives ABHES Institutional Accreditation for Long Distance Education
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... -- Royal Philips (NYSE: PHG AEX: PHIA) ... 56th Annual Meeting in San Francisco ... consistency and accuracy in cancer treatment. Producing quality results ... oncology solutions underscore Philips, dedication to leading healthcare into ... "Philips is leveraging our expertise in CT, ...
(Date:9/12/2014)... MARIETTA, Ga. , Sept. 12, 2014  WellStar ... Georgia and became the second in the ... sleep apnea.  As part of WellStar Health System, Paulding ... continually offering the latest treatments and solutions. ... sleep apnea in patients who are unable to use ...
(Date:9/12/2014)... According to the new research ... Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by ... & Prescription Based - Global Forecast to 2018" published ... over the forecast period of 2013 to 2018. The ... 9.3% from 2013 to 2018, to reach $27.5 billion ...
Breaking Medicine Technology:Philips Demonstrates Commitment to Radiation Oncology Solutions at ASTRO 2014 2Philips Demonstrates Commitment to Radiation Oncology Solutions at ASTRO 2014 3WellStar Pioneers New Sleep Apnea Treatment 2Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 2Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 3Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 4
... May 16, 2011 /PRNewswire-Asia/ -- Global Pharm Holdings ... "Company"), a China-based leading vertically integrated pharmaceutical company ... cultivation businesses through its subsidiaries in the Anhui, ... financial results for the first quarter ended March ...
... MAYWOOD, N.J., May 16, 2011 New Jersey Center ... sites in the nation to treat advanced prostate cancer ... therapeutic class known as autologous cellular immunotherapies.  PROVENGE was ... for the treatment of men with asymptomatic or minimally ...
Cached Medicine Technology:Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 2Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 3Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 4Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 5Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 6Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 7Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 8Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 9Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 10Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 11New Jersey Center for Prostate Cancer & Urology Among First in Nation to Treat Advanced Prostate Cancer Patients with PROVENGE 2
(Date:9/14/2014)... 14, 2014 UWDress.com, is an internationally ... has recently announced its new range of cocktail ... bring more benefits to worldwide ladies, the company is ... lace wedding outfits, blue evening gowns, black formal gowns ... 70 percent off. , The company’s senior spokesman ...
(Date:9/13/2014)... (PRWEB) September 13, 2014 East ... a renowned Vancouver chiropractic clinic, has recently published ... In this latest blog on the topic, Dr ... clarified several myths that people have regarding this ... between the services of a chiropractor and that ...
(Date:9/13/2014)... -- Researchers say they,ve tracked specific activity in the ... clear whether imagination and memory were distinct processes, so ... decided to explore the issue. "I was thinking ... imagining myself in the future, and I started wondering ... Ashby said in a university news release. "I ...
(Date:9/13/2014)... Top10BestSEOHosting.com is a well-known review website the ... web hosting suppliers and announced that FatCow ( ... ASP.NET hosting suppliers in 2014. According to the ... very popular way for webmasters to build dynamic ... is happy to introduce Arvixe, FatCow.com, and Hostgator ...
(Date:9/13/2014)... (PRWEB) September 13, 2014 New York is ... declaring September 23, 2014, Falls Prevention Awareness Day. , ... injuries for those 65 years of age and over. Every ... department for a fall-related injury. Every day because of a ... New Yorkers are hospitalized; and two New Yorkers die. The ...
Breaking Medicine News(10 mins):Health News:UWDress.com: Elegant Cocktail Dresses Under $100 Now Offered 2Health News:East Vancouver Chiropractor Releases Blog to Bust Myths about Chiropractic Medicine 2Health News:Scientists Watch Imagination at Work in the Brain 2Health News:Best ASP.NET Hosting Suppliers in 2014 Unveiled By Top10BestSEOHosting.com 2Health News:The New York Physical Therapy Association Supports a Strong Today – Falls Free® Tomorrow on Falls Prevention Awareness Day 2Health News:The New York Physical Therapy Association Supports a Strong Today – Falls Free® Tomorrow on Falls Prevention Awareness Day 3Health News:The New York Physical Therapy Association Supports a Strong Today – Falls Free® Tomorrow on Falls Prevention Awareness Day 4
... BEDFORD, Mass., Sept. 2 Hologic, Inc. (Nasdaq: HOLX ... at the 2009 Morgan Stanley Global Healthcare Unplugged Conference in New ... , , Interested parties are invited to ... the investor section of the company,s website at www.hologic.com/investor ...
... not create ,safety concern, agency says , WEDNESDAY, Sept. 2 ... many lipsticks are higher than those reported in 2007 by ... new analysis, conducted by the U.S. Food and Drug Administration ... of Cosmetic Science , used new techniques to determine the ...
... , , , ... the American Veterinary Medical Association (AVMA), was named chief executive officer ... to highlight the connections between human, animal, and environmental health. , ... group,s first board of directors meeting on August 14 in Washington, ...
... PHILADELPHIA (September 2, 2009) The Fox Chase Cancer ... National Center for Research Resources of the National Institutes ... facility. The new facility will support advanced ... the way for the development of new treatments. The ...
... space, may be the stuff dreams are made of. ... in those clouds, and it,s not dreams butmothballs? ... Georgia have just shown for the first time that ... as the Unidentified Infrared Bands (UIRs) is a gaseous ...
... Post study, approximately 20% of U.S. soldiers returning from ... a substantial number with post-traumatic stress disorder (PTSD), and ... become unacceptable to Army commanders and the soldiers, families. ... however, doctors will now be able to forecast a ...
Cached Medicine News:Health News:Lead Levels in Many Lipsticks Higher Than Reported 2Health News:Lead Levels in Many Lipsticks Higher Than Reported 3Health News:Former AVMA President to Head National Health Commission 2Health News:Fox Chase Cancer Center receives $8 million NIH grant to expand laboratory animal research facility 2Health News:University of Georgia researchers show component of mothballs is present in deep-space clouds 2Health News:University of Georgia researchers show component of mothballs is present in deep-space clouds 3Health News:Keeping the suicidal soldier alive 2
0.2ml Gradient Block MBSR. Robot compatible block ejection mechanism. Stackable. (96 well block - holds 1 plate 0.2ml x 96 well plate)...
... PxE Thermal Cycler (PxE) is a licensed 96 ... features for value for money thermal cycling. ... sixteen years experience in manufacturing and retains a ... synonymous with other products in the range. ...
Custom programming of 3 hot blocks and 1 cold block, 30% reduction in cycling time, Unmatched well-to-well uniformity, No gradient feature...
... With Exceptional Performance The sleek ... might be the first things ... is designed for performance. With ... premium, its small footprint is ...
Medicine Products: